Organizzazione ed analisi quinquennale di una banca dati di Pap Test eseguiti su un campione di popolazione generale: confronto con altri dati di riferimento

Bibliografia


Edelman M., Fox S A, Alderman E M, Neal W, Shapiro A, Silver E J, Spigland I, Suhrland M.
Cervical Papanicolau smear  abnormalities in inner city Bronx Adolescents.
Cancer 1999 Aug; 87 (4): 184-189.

Segnana N, Ronco G, Ciatto S.
Cervical cancer screening in Italy.
Eur J Cancer 2000; 36: 2235-39.

Sigurdsson K.
Quality assurance in cervical cancer screening: the Icelandic experience 1964-1993.
Eur J Cancer 1995; 31A (5): 728-734.

Cecchini S, Grazzini G, Bonardi R, Ciatto S.
Quality control in cytologic screening.
Acta Cytol. 1993 May-Jun; 37(3): 436.

Slater D.
Cervical cytology internal quality assurance-what are national standards?
Cytopathology 1994 Aug; 5 (4): 207-210.

Patnick J.
Cervical screening: quality assurance developments in Europe.
Eur J Gynaecol Oncol. 2000; 21 (5): 437-8.

Coleman D, Day N, Douglas G, Farmery E, Lynge E, Philip J, Segnan N.
European Guidelines for quality assurance in cervical cancer screening. Europe against cancer programme.
Eur J  Cancer 1993; 29A Suppl. 4: S1-38.

Schaffer P, Sancho-Garnier H, Fender M, Dellenbach P, Carbillet JP, Monnet E, Gauthier GP,
Garnier A.
Cervical cancer screening in France,.
Eur J Cancer 2000 Nov; 36 (17): 2215-20.

Labbe S, Petitjean A.
False negatives and quality assurance in cervico-uterine cytology.
Ann Pathol. 1999 Oct; 19 (5): 457-62.

Cosentino A, Ghidoni D, Salemi M, Folicaldi S, Aamadori A, Zani J, Grasso G, Bondi A.
An interlaboratory study of the use of PapNet in the quality control of cervico-vaginal cytology.
Pathologica 1999 Apr; 91 (2): 101-6.

Mintzer M, Curtis P, Resnick JC, Morrel D.
The effect of the quality of Papanicolau smears on the detection of cytologic abnormalities.
Cancer 1999 Jun 25; 87 (3):113-7.

Light AM.
Quality assurance in cervical cytopathology.
Cytopathology 1997 Aug; 8 (4): 290-2.

Segnan N, Ronco G, Ciatto S.
Cervical cancer screening in Italy.
 Eur J Cancer 2000 Nov; 36(17):2235-9.

Walsh JM
Cervical cancer: developments in screening and evaluation of the abnormal pap smear.
West J Med  1998 Nov; 169 (5): 304-10

Foulks MJ
The Papanicolau smear: its impact on the promotion of women's health.
J Obstet Gynecol Neonatal Nurs 1998 Jul-Aug; 27 (4) 367-73.

Sawaya GF, Kerlikowskw K, Lee NC, Gildengorin G, Washington AE.
Frequency of cervical smear abnormalities within 3 years of normal cytology.
Obstet Gynecol 2000 Aug; 96 (2): 219-23.

Chiosa M, Marsan C, Ferrand J, Domagala W.
Quality control in cytodiagnosis of carcinoma of the cervix.
Pol J Pathol 2000; 51 (2): 87-91.

Spitzer M.
Cervical screening adjuncts: recent advances.
Am J Obstet Gynecol 1998 Aug; 179 (2): 544-56.

Coleman D.
Quality control in the screening of cervical cancer.
Klin Lab Diagn. 1995 Nov-Dec; (6): 99-101.